There has always been a simple solution to this: it is the company's own job to clearly demonstrate that it has a working technology.
If you view it that way, then the press's inability to prove it one way or the other doesn't matter because the responsibility lies with the company. In fact, Theranos was quite unusual among lab companies from the beginning in that it didn't follow the path other companies followed in showing they had a working technology. Anything less than a clear proof by the company, and the subsequent confusion is the company's own fault.
There have been empirical actions which resulted based on Theranos's errors, including FDA/SEC investigations and Walgreens revoking their partnership. Those aren't media spins.
There is a difference between the tech that doesn't work and tech that cannot work.
The former will work eventually, but the latter can never work.
Can you tell which it is?
Famously Walgreen's didn't do due diligence.
> There is a difference between the tech that doesn't work and tech that cannot work.
It was already pretty well known that blood concentrations vary enough in the body that you need large samples to get reproducible results. Life science VCs all passed on this deal. The fundamental science was not there.
Note: I have worked in pharma and designed successful clinical trials.
http://www.wsj.com/article_email/theranos-voids-two-years-of... ??
In other words:
1. Is it fraud and poor science? 2. Is it good science but still immature?
That is the key distinction.
If it did work, it would be straightforward for them to demonstrate that it did.
I can't tell if it never worked, or if something prevented it from scaling.
The interesting thing here is that we can't just say that's not true.
I am not making a larger point about solipsism or our inability to know reality. I mean the much narrower point of not being able to tell -- from the press -- whether a company actually has a technology that works.
Think about the implications that has for investing in public stocks.
Let's ignore the cases of fraud like Enron etc., and focus on an ordinary company that honestly reports what it is doing.
EDIT: I have followed the Theranos story, so I know about the legal actions etc.
What I can't tell is if there is poor science at the heart of it, or it is a case of poor scaling and application of good science.